When do paediatric patients with familial hypercholesterolemia need statin therapy?^*

1Austin MA, Hutter CM, Zimmern RL, et al. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. American Journal of Epidemiology 2004;160:421-429.Austin MA Hutter CM Zimmern RL et al Familial hypercholesterolemia and coronary heart disease: a HuGE association review American Journal of Epidemiology 2004160421 42910.1093/aje/kwh23715321838Search in Google Scholar

2Catapano AL, Reiner Z, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidemia of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217(1):3-46.Catapano AL Reiner Z De Backer G et al ESC/EAS Guidelines for the management of dyslipidemia of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Atherosclerosis 201121713 4610.1016/j.atherosclerosis.2011.06.02821882396Search in Google Scholar

3Familial Hypercholesterolemia. A report of a WHO consultation. WHO. Geneva, Switzerland, 1998.Familial Hypercholesterolemia. A report of a WHO consultation. WHO Geneva, Switzerland 1998Search in Google Scholar

4Myśliwiec M, Walczak M, Małecka-Tendera E, el al. Stanowisko dotyczące postępowania w rodzinnej hipercholesterolemii u dzieci i młodzieży. Stanowisko Forum Ekspertów Lipidowych. Pediatria Polska 2013;88:567-574.Myśliwiec M Walczak M Małecka-Tendera E el al Stanowisko dotyczące postępowania w rodzinnej hipercholesterolemii u dzieci i młodzieży. Stanowisko Forum Ekspertów Lipidowych Pediatria Polska 201388567 57410.1016/j.pepo.2013.09.001Search in Google Scholar

5Jourdan C, Wühl E, Litwin M, et al. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. Journal of Hypertension 2005;23:1707-1715.Jourdan C Wühl E Litwin M et al Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents Journal of Hypertension 2005231707 171510.1097/01.hjh.0000178834.26353.d516093916Search in Google Scholar

6Calabro MP, Carej S, Russo MS, et al. Normal paediatric values of arterial stiffness parameters measured by echo-tracking. The child, a Journal of Pediatrics 2012;Vol 1, No. 1.Calabro MP Carej S Russo MS et al Normal paediatric values of arterial stiffness parameters measured by echo-tracking The child, a Journal of Pediatrics 2012Vol 1 No. 1Search in Google Scholar

7Wiegman A, Hutten BA, De Groot E, et al. E' cacy and safety of statin therapy in children with familial hypercholesterolemia. A randomized controlled trial. Jama 2004; 292(3):331-337.Wiegman A Hutten BA De Groot E et al E' cacy and safety of statin therapy in children with familial hypercholesterolemia A randomized controlled trial. Jama 2004 2923331 33710.1001/jama.292.3.33115265847Search in Google Scholar

8Joyce L Ross. Statins in the Management of Pediatric. Journal of Pediatric Nursing 2016.Joyce L Ross Statins in the Management of Pediatric Journal of Pediatric Nursing 201610.1016/j.pedn.2016.07.00427496827Search in Google Scholar

9Nordestgaard BD, Chapman MJ, Humphires SE. Familial hypercholestaerolemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. European Heart Journal 2013;34:3478-3490.Nordestgaard BD Chapman MJ Humphires SE Familial hypercholestaerolemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease European Heart Journal 2013343478 349010.1093/eurheartj/eht273384415223956253Search in Google Scholar

10Undas A, pod red. Podolec P. Zaburzenia lipidowe − kogo i kiedy należy objąć badaniem przesiewowym. Podręcznik Polskiego Forum Pro#laktyki T.2. Kraków: Med Prakt. 2010.Undas A pod red Podolec P Zaburzenia lipidowe − kogo i kiedy należy objąć badaniem przesiewowym. Podręcznik Polskiego Forum Pro#laktyki T.2. Kraków: Med Prakt 2010Search in Google Scholar

11Walldius G, Aastveit AH, Junger I. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study. Journal of Internal Medicine 2006;259:259-266.Walldius G Aastveit AH Junger I Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study Journal of Internal Medicine 2006259259 26610.1111/j.1365-2796.2005.01610.x16476103Search in Google Scholar

12Riggio S, Mandra' no G, Sardo MA, et al. Pulse wave velocity and augumentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Invest. 2010;40(3):250-257.Riggio S Mandra' no G Sardo MA et al Pulse wave velocity and augumentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children Eur J Clin Invest 2010403250 25710.1111/j.1365-2362.2010.02260.x20415700Search in Google Scholar

13Sobień B, Kopeć G, Podolec P. Statyny. Podręcznik Polskiego Forum Pro#laktyki T.2. Kraków: Med Prakt. 2010.Sobień B Kopeć G Podolec P. Statyny Podręcznik Polskiego Forum Profilaktyki T.2. Kraków: Med Prakt 2010Search in Google Scholar

14Kamińska E, Hennig M, Brandt A, Bautembach Minkowska J, Myśliwiec M. Treatment with statins in children with familial hypercholesterolemia,Developmental Period Medicine 2016;XX;4:328-334.Kamińska E Hennig M Brandt A Bautembach Minkowska J Myśliwiec M Treatment with statins in children with familial hypercholesterolemia Developmental Period Medicine 2016XX4328 334Search in Google Scholar